Prudential Financial Inc Rvl Pharmaceuticals PLC Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.21 - $1.81 $30,250 - $45,250	25,000 New	25,000 $34,000
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $409,052 - $552,220	-146,090 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$3.26 - $4.84 $40,293 - $59,822	-12,360 Reduced 7.8%	146,090 $476,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $8.77 $596,634 - $1.09 Million	123,783 Added 357.06%	158,450 $857,000
Q2 2020 Aug 12, 2020	BUY	$2.83 - $6.99 $98,107 - $242,322	34,667 New	34,667 $233,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.